Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice

Faizan Mazhara Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
View further author information

Åsa Krantzb Dermatology and Venereology Section, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;c Unit of Dermatology, Karolinska University Hospital, Stockholm, SwedenView further author information

Lovisa Schalind Epidemiology, Amgen, SwedenView further author information

Josefin Lysellb Dermatology and Venereology Section, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;c Unit of Dermatology, Karolinska University Hospital, Stockholm, SwedenView further author information

Juan Jesus Carreroa Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;e Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, SwedenView further author information

Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date